Directed-Evolution Analysis of Human Cytochrome P450 2A6 for Enhanced Enzymatic Catalysis

REFERENCES

• Agudo, R., Roiban, G. D., and Reetz, M. T. 2012. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution. Chembiochemistry 13: 1465–1473.
   PubMed Web of Science ®Google Scholar
• Bernhardt, R. 2006. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124: 128–145.
   PubMed Web of Science ®Google Scholar
• Brewton, R. A, Fulford, R., and Griffitt, R. J. 2013. Gene expression and growth as indicators of effects of the BP Deepwater Horizon oil spill on spotted seatrout (Cynoscion nebulosus). J. Toxicol. Environ. Health A. 76: 1198–1209.
   PubMed Web of Science ®Google Scholar
• Chiang, H. C., Wang, C. Y., Lee, H. L., and Tsou, T. C. 2011. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation—A mammalian cell-based mutagenesis approach. Toxicol. Appl. Pharmacol. 253: 145–152.
   PubMed Web of Science ®Google Scholar
• Choi, S., Han, S., Lee, H., Chun, Y. J., and Kim, D. 2013. Evaluation of luminescent P450 analysis for directed evolution of human CYP4A11. Biomol. Ther. 21: 487–492.
   PubMed Web of Science ®Google Scholar
• Fasan, R., Meharenna, Y. T., Snow, C. D., Poulos, T. L., and Arnold, F. H. 2008. Evolutionary history of a specialized p450 propane monooxygenase. J. Mol. Biol. 383: 1069–1080.
   PubMed Web of Science ®Google Scholar
• Fujita, K., and Kamataki, T. 2001. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: Application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase. Mutat. Res. 483: 35–41.
   PubMed Web of Science ®Google Scholar
• Gillam, E. M., Aguinaldo, A. M., Notley, L. M., Kim, D., Mundkowski, R. G., Volkov, A. A., Arnold, F. H., Soucek, P., DeVoss, J. J., and Guengerich, F. P. 1999. Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265: 469–472.
   PubMed Web of Science ®Google Scholar
• Gillam, E. M., and Hayes, M. A. 2013. The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development. Curr. Top. Med. Chem. 13: 2254–2280.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 2002. Cytochrome P450 enzymes in the generation of commercial products. Nat. Rev. Drug Discov. 1: 359–366.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 2008. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 21: 70–83.
   PubMed Web of Science ®Google Scholar
• Han, S., Choi, S., Chun, Y. J., Yun, C. H., Lee, C. H., Shin, H. J., Na, H. S., Chung, M. W., and Kim, D. 2012. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol. Pharm. Bull. 35: 394–399.
   PubMed Web of Science ®Google Scholar
• Joo, H., Lin, Z., and Arnold, F. H. 1999. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature 399: 670–673.
   PubMed Web of Science ®Google Scholar
• Juvonen, R. O., Iwasaki, M., and Negishi, M. 1991. Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis. J. Biol. Chem. 266: 16431–16435.
   PubMed Web of Science ®Google Scholar
• Kille, S., Zilly, F. E., Acevedo, J. P., and Reetz, M. T. 2011. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution. Nat. Chem. 3: 738–743.
   PubMed Web of Science ®Google Scholar
• Kim, D., and Guengerich, F. P. 2004a. Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding. Arch. Biochem. Biophys. 432: 102–108.
   PubMed Web of Science ®Google Scholar
• Kim, D., and Guengerich, F. P. 2004b. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation. Biochemistry 43: 981–988.
   PubMed Web of Science ®Google Scholar
• Kim, D., Wu, Z. L., and Guengerich, F. P. 2005. Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J. Biol. Chem. 280: 40319–40327.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Chen, C. S., Waxman, D. J., and Halpert, J. R. 2005. Directed evolution of mammalian cytochrome P450 2B1: Mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide. J. Biol. Chem. 280: 19569–19575.
   PubMed Web of Science ®Google Scholar
• Lauer, F. T., Walker, M. K., and Burchiel, S. W. 2013. Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice. J. Toxicol. Environ. Health A. 76: 16–24.
   PubMed Web of Science ®Google Scholar
• Lewis, J. C., Bastian, S., Bennett, C. S., Fu, Y., Mitsuda, Y., Chen, M. M., Greenberg, W. A., Wong, C. H., and Arnold, F. H. 2009. Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450BM3 demethylases. Proc. Natl. Acad. Sci. USA 106: 16550–16555.
   PubMed Web of Science ®Google Scholar
• Nakamura, K., Martin, M. V., and Guengerich, F. P. 2001. Random mutagenesis of human cytochrome P450 2A6 and screening with indole oxidation products. Arch. Biochem. Biophys. 395: 25–31.
   PubMed Web of Science ®Google Scholar
• Nash, J. T., Szabo, D. T., and Carey, G. B. 2013. Polybrominated diphenyl ethers alter hepatic phosphoenolpyruvate carboxykinase enzyme kinetics in male Wistar rats: Implications for lipid and glucose metabolism. J. Toxicol. Environ. Health A. 76: 142–156.
   PubMed Web of Science ®Google Scholar
• Negishi, M., Uno, T., Honkakoski, P., Sueyoshi, T., Darden, T. A., and Pedersen, L. P. 1996. The roles of individual amino acids in altering substrate specificity of the P450 2a4/2a5 enzymes. Biochimie 78: 685–694.
   PubMed Web of Science ®Google Scholar
• Parikh, A., Josephy, P. D., and Guengerich, F. P. 1999. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 38: 5283–5289.
   PubMed Web of Science ®Google Scholar
• Park, H. G., Lee, I. S., Chun, Y. J., Yun, C. H., Johnston, J. B.,Ortiz de Montellano, P. R. and Kim, D. 2011. Heterologous expression and characterization of the sterol 14alpha-demethylase CYP51F1 from Candida albicans. Arch. Biochem. Biophys. 509: 9–15.
   PubMed Web of Science ®Google Scholar
• Rajpoot, D. S., Prakash, A., Mandil, R., Rahal, A., and Garg, S. K. 2013. Differential modulation of xenobiotic-metabolizing enzymes in rats following single and concurrent exposure to chlorpyrifos, arsenic, and ascorbic acid. J. Toxicol. Environ. Health A 76: 1354–1365.
   PubMed Web of Science ®Google Scholar
• Rendic, S., and Guengerich, F. P. 2012. Contributions of human enzymes in carcinogen metabolism. Chem. Res. Toxicol. 25: 1316–1383.
   PubMed Web of Science ®Google Scholar
• Schick, S. F., van den Vossenberg, G., Luo, A., Whitlatch, A., Jacob, P. 3rd, Balmes, J., and Shusterman, D. 2013. Thirty minute-exposure to aged cigarette smoke increases nasal congestion in nonsmokers. J. Toxicol. Environ. Health A 76: 601–613.
   PubMed Web of Science ®Google Scholar
• Shimada, T., Kim, D., Murayama, N., Tanaka, K., Takenaka, S., Nagy, L. D., Folkman, L. M., Foroozesh, M. K., Komori, M., Yamazaki, H., and Guengerich, F. P. 2013a. Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem. Res. Toxicol. 26: 517–528.
   PubMed Web of Science ®Google Scholar
• Shimada, T., Murayama, N.,Yamazaki, H., Tanaka, K., Takenaka, S., Komori, M., Kim, D., and Guengerich, F. P. 2013b. Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6. Chem. Res. Toxicol. 26: 529–537.
   PubMed Web of Science ®Google Scholar
• Whitehouse, C. J., Yang, W., Yorke, J. A., Tufton, H. G., Ogilvie, L. C., Bell, S. G., Zhou, W., Bartlam, M., Rao, Z., and Wong, L. L. 2011. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant. Dalton Trans. 40: 10383–10396.
   PubMed Web of Science ®Google Scholar
• Wu, Z. L., Aryal, P., Lozach, O., Meijer, L., and Guengerich, F. P. 2005a. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6. Chem. Biodivers. 2: 51–65.
   PubMed Web of Science ®Google Scholar
• Wu, Z. L., Podust, L. M., and Guengerich, F. P. 2005b. Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis. J. Biol. Chem. 280: 41090–41100.
   PubMed Web of Science ®Google Scholar
• Yamazaki, H., Inui, Y., Yun, C. H., Guengerich, F. P., and Shimada, T. 1992. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13: 1789–1794.
   PubMed Web of Science ®Google Scholar
• Yano, J. K., Hsu, M. H., Griffin, K. J., Stout, C. D., and Johnson, E. F. 2005. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat. Struct. Mol. Biol. 12: 822–823.
   PubMed Web of Science ®Google Scholar
• Yun, C. H., Shimada, T., and Guengerich, F. P. 1991. Purification and characterization of human liver microsomal cytochrome P450 2A6. Mol. Pharmacol. 40: 679–685.
   PubMed Web of Science ®Google Scholar
• Zhang, Z. G., Liu, Y., Guengerich, F. P., Matse, J. H., Chen, J., and Wu, Z. L. 2009. Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries. J. Biotechnol. 139: 12–18.
   PubMed Web of Science ®Google Scholar